Low Centyl K

Quick links to important sections

Low Centyl K

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Low Centyl K

Quick Facts: Low Centyl K Identity

Property Description
Active Ingredients Bendroflumethiazide, Potassium Chloride
Form Modified-release tablet
Pharmacological Class Thiazide Diuretic and Electrolyte Supplement
Type Fixed-Dose Combination Product
Origin Synthetic compound combined with a mineral salt

What Type of Medicine is Low Centyl K?

Low Centyl K is classified as a fixed-dose combination product delivered as a modified-release oral tablet. This formulation uniquely integrates the fluid-regulating effects of a diuretic with the necessary protection of an electrolyte supplement. The formulation's dual nature includes Bendroflumethiazide, a synthetic compound belonging to the thiazide diuretic class, and Potassium Chloride, a critical inorganic mineral salt. The structure is engineered for oral administration, with the modified-release tablet being a differentiating factor that promotes sustained activity over traditional immediate-release forms, a characteristic recognized in managing long-term fluid balance.


Composition and Pharmacological Class of Low Centyl K

The active composition of Low Centyl K centers on Bendroflumethiazide and Potassium Chloride. Bendroflumethiazide is defined as a thiazide diuretic that acts on the kidneys to increase the urinary excretion of sodium, chloride, and water. This class of drug is recognized for its effects on circulatory fluid volume. The second component, Potassium Chloride, serves as an electrolyte replenisher, classifying it as a potassium supplement. This co-formulation is utilized because diuretics often increase the urinary loss of potassium ions, and the supplement component helps counteract this specific effect to maintain internal balance.


General Purpose and Mechanism of Low Centyl K

The general purpose of Low Centyl K is to achieve fluid balance by increasing salt and water excretion while simultaneously ensuring the maintenance of stable potassium levels in the body. The diuretic component effectively reduces the body's overall fluid volume, a typical use scenario for managing conditions linked to fluid retention. Critically, the integrated potassium ensures essential electrolyte balance is preserved, which is vital for proper muscle and nerve function. The overall formulation is designed to provide a comprehensive therapeutic approach to managing fluid volume while minimizing the risk of potassium depletion.

What side effects are possible with Low Centyl K?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety constraints documented in official government regulatory labeling for Low Centyl K. The information is categorized by frequency and the body system affected, strictly excluding dosing instructions, therapeutic uses, or medical advice.


Adverse Reactions and Frequencies

Adverse reactions are classified based on the frequency documented in regulatory reports:

Frequency Examples of Adverse Reactions (by SOC)
Common (1 in 10 to 1 in 100) Nausea, vomiting, dyspepsia (Gastrointestinal Disorders); rash (Skin)
Uncommon (1 in 100 to 1 in 1,000) Muscle weakness (Musculoskeletal); palpitations, elevated blood pressure (Cardiac Disorders)
Rare (1 in 1,000 to 1 in 10,000) Severe hypersensitivity reactions (Immune System); ventricular arrhythmias (Cardiac Disorders); gastrointestinal ulceration (Gastrointestinal)
Frequency Not Known Rhabdomyolysis (Musculoskeletal); hepatic enzyme elevation (Hepatobiliary Disorders)

Serious Adverse Reactions (SAR) and Safety Constraints

Serious Adverse Reactions highlighted in official labeling include ventricular arrhythmias (e.g., Torsade de Pointes), gastrointestinal ulceration or bleeding, and severe hypersensitivity reactions. The product label contains a boxed warning regarding the risk of severe cardiac arrhythmia due to potential electrolyte disturbances.

Safety Restrictions and Monitoring:

  • Mandatory Monitoring: Use requires mandatory periodic monitoring of serum electrolytes and renal function.
  • Renal Impairment: Use is restricted to patients with an eGFR greater than 30 mL/min/1.73 m^2.
  • Time-Related Pattern: The risk of gastrointestinal ulceration is documented to increase with extended duration of therapy (greater than six months).

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section is derived strictly from official government regulatory documentation concerning documented overdose manifestations and emergency actions.

Overdose with Low Centyl K (Bendroflumethiazide and Potassium Chloride) is characterized by an exaggeration of its known physiological effects, primarily involving severe fluid and electrolyte disturbances. Documented clinical manifestations of overdose include profound diuresis, significant hypotension (low blood pressure), dehydration, and signs of volume depletion. Patients may experience associated symptoms such as lethargy, weakness, dizziness, and nausea.

Serious Outcomes and Emergency Action

Serious or life-threatening outcomes listed in official prescribing information are primarily related to critical electrolyte shifts and circulatory instability. These can include severe cardiac dysrhythmias, circulatory collapse, and cardiac arrest. The regulatory documents state that no specific antidote is known for Bendroflumethiazide overdose, and management focuses on supportive care.

In the event of a suspected overdose, regulatory guidance mandates that patients seek immediate medical attention. This requires contacting emergency services or proceeding directly to a hospital emergency department. Hospital monitoring, including continuous ECG monitoring and frequent assessment of serum electrolytes, is necessary to manage complications like hyperkalemia or severe hyponatremia and to correct the underlying fluid and electrolyte imbalance.

Therapeutic Uses of Low Centyl K

Quick Facts: Low Centyl K

  • May assist in the management of high blood pressure (hypertension).
  • Can be used to help address excess fluid retention in the body.
  • May be utilized to help resolve or prevent low potassium levels (hypokalemia).

What Low Centyl K Treats: Main Uses and Benefits

Low Centyl K is a treatment that may be prescribed by a healthcare professional for the management of elevated blood pressure, a condition often referred to as hypertension. Its use is associated with assisting the body in the process of reducing fluid volume, which may contribute to managing the blood pressure.

The regimen may be employed to address instances of low potassium levels (hypokalemia), which can occur when the body loses potassium. The formulation can be used in the context of treating or helping to prevent this electrolyte imbalance. Its therapeutic role centers on supporting the overall fluid and electrolyte balance in the body, which is important for health management.

Eligibility and Restrictions for Use

Low Centyl K, a fixed-dose combination containing the thiazide diuretic bendroflumethiazide and potassium chloride, is prescribed primarily for the treatment of hypertension (high blood pressure) and edema (fluid retention) associated with conditions such as heart failure. It is also used to prevent hypokalemia (low potassium levels) often caused by the diuretic component.


Who Should Not Use Low Centyl K

This medication is not suitable for everyone. Contraindications include:

  • Known allergy to bendroflumethiazide, potassium chloride, or sulfonamide-derived drugs.
  • Severe kidney or liver impairment or inability to urinate (anuria).
  • Pre-existing hyperkalemia (high potassium levels) or other severe electrolyte imbalances (e.g., hypercalcemia).
  • Conditions such as Addison's disease or gout.
  • Known obstruction or ulceration of the gastrointestinal tract, as potassium chloride can exacerbate these conditions.
  • It is generally not recommended during pregnancy or breastfeeding, unless a physician determines the potential benefit outweighs the risk.

Use with Caution

Special medical monitoring is required for patients with:

  • Diabetes mellitus (due to potential effects on blood sugar).
  • Systemic lupus erythematosus (SLE).
  • Mild to moderate renal or hepatic impairment.
  • A history of or predisposition to gout or high uric acid levels (hyperuricemia).

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Low Centyl K, a fixed-dose combination of Bendroflumethiazide and Potassium Chloride, is defined by substances that affect electrolyte balance and drug concentration, based on regulatory documentation.

Formally Documented Restrictions

Co-administration with potassium-sparing diuretics (e.g., Spironolactone, Amiloride) is contraindicated due to the high risk of severe hyperkalaemia resulting from the Potassium Chloride component. Similarly, combining with antipsychotics like Pimozide or Thioridazine is strongly restricted due to the increased risk of cardiac rhythm disturbances associated with the hypokalaemic effect of Bendroflumethiazide.

Exposure and Pharmacodynamic Interactions

The diuretic component inhibits the renal elimination of Lithium, which significantly increases plasma Lithium concentrations and heightens the risk of toxicity. The absorption of Bendroflumethiazide is formally documented to be reduced by Bile-Acid Binding Resins (e.g., Colestyramine), necessitating a timing separation (e.g., 2 hours before or after) of administration.

Agents such as ACE Inhibitors and Angiotensin II Receptor Antagonists increase the risk of hyperkalaemia. Additionally, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may officially antagonise the diuretic effect, potentially reducing fluid-regulating action. Patients with impaired renal function are cited in labeling as having a greater risk of interaction-related hyperkalaemia.

Mechanism of Action

Low Centyl K is a fixed-dose combination containing bendroflumethiazide and potassium chloride.

Bendroflumethiazide, a thiazide-class agent, functions as a competitive inhibitor of the Na^+/ Cl^- cotransporter (NCC) located on the apical membrane of epithelial cells in the distal convoluted tubule of the nephron. This molecular interaction blocks the reabsorption of luminal Na^+ and Cl^-, which in turn increases their delivery to the collecting duct. This intracellular pathway leads to an increased osmotic pressure within the tubule lumen, resulting in reduced water reabsorption and a subsequent increase in urinary water excretion—the process of diuresis.

The increased Na^+ concentration in the collecting duct stimulates the Na^+/ K^+ exchange mechanism, leading to enhanced urinary excretion of K^+ and H^+. The resulting system-level physiological consequence of this downstream cascade is a net reduction in extracellular fluid volume. Furthermore, bendroflumethiazide induces vasodilation via a separate mechanism involving the activation of large conductance Ca^2+-activated K^+ channels (KCa) in vascular smooth muscle.

Potassium chloride provides exogenous K^+ and Cl^- ions. The K^+ ion is essential for maintaining cell membrane potential, nerve impulse transmission, muscle contraction, and overall cellular function. The system-level consequence of its absorption is an increase in total body potassium and serum potassium concentration.

Dosage and Administration Information

Low Centyl K is a fixed-dose combination product prescribed for oral administration as a modified-release tablet. The medicine is taken once daily, with the standard regimen for the management of high blood pressure being one tablet daily. For the management of fluid retention (oedema), the initial dosage may range from one to four tablets once daily, which is typically adjusted to a maintenance dose of one to two tablets daily. Dosing focuses on adult posology, and no specific pediatric regimen is detailed.

The administration of the modified-release tablet is contingent upon specific requirements. To optimize tolerance and release, the tablet is taken with or immediately following a meal (food) and accompanied by at least a full glass of water or fluid. The daily dose is typically taken in the morning. This timing is designed to align with daily activity patterns and reduce the likelihood of nocturia (waking up to urinate at night).

The modified-release tablet is intended to be swallowed whole. Due to the specialized structure, the tablet must not be crushed, chewed, or sucked under any circumstances.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Mechanism and Scope

Studies explored areas of biological function, including inflammation and pain signal transmission. Studies assessed changes in function and pain levels. A review of clinical trials evaluated the onset and duration of effect. Several large-scale trials have reported findings related to the duration of reduced symptoms.


Key Clinical Findings

Clinical studies evaluated the use of the drug in individuals with varying symptom severity and over extended periods.

  • Primary Outcome Trials: Initial randomized controlled trials (RCTs) primarily focused on short-term efficacy, examining symptom changes over a 4-to-12 week period.
  • Long-term Safety Data: Post-market surveillance and open-label extension studies have provided data on the safety profile when the drug was studied for longer than one year.

Combination and Comparative Research

Research examined the effects of combination therapy, pairing the drug with standard physical exercise, on mobility.

Comparative studies analyzed the safety profile of the drug against other treatments.

  • Dose-Ranging Studies: Dose-ranging studies evaluated the relationship between dosage level and reported effects in individuals with mild symptoms.
  • Pain Subtype Evaluation: Studies evaluated the drug's effect on various types of chronic joint pain.

Side Effects and Risk Profile

The most frequently reported side effects in clinical trials included gastrointestinal upset and headache. Research has explored the incidence of more severe adverse events, and findings are documented in the detailed study publications. Patients in the studies were monitored for changes in liver and kidney function throughout the trial period.

Frequently Asked Questions (FAQ)

Common questions about Low Centyl K (FAQ)


Q: Are there different strengths or dosages of Low Centyl K available?

Official product information, such as the SmPC, details the specific strengths and available fixed-dose combinations of the active ingredients in Low Centyl K. The medicine is available in specific tablet forms that combine bendroflumethiazide and potassium chloride.

Q: Why do official documents state that people with certain kidney issues should not use Low Centyl K?

Regulatory documents indicate that Low Centyl K is contraindicated (should not be used) in individuals with severe kidney problems or severe liver issues. Official documents cite the risk of hyperkalemia (dangerously high potassium levels) and other electrolyte imbalances as a key concern in these situations, as the kidneys regulate these minerals.

Q: Why is the daily dose recommended to be taken in the morning?

Official prescribing guidance specifies that the daily dose should be taken in the morning. This administration schedule is intended to reduce the chance of nocturia, which refers to waking up frequently during the night because of the need to urinate.

Q: What is the general profile of side effects for Low Centyl K?

Official patient information classifies side effects by frequency. Common effects listed in official documents include stomach upset, nausea, headache, or dizziness. Less common but important severe effects are also listed, and documentation advises seeking medical attention if those occur.

Q: Does Low Centyl K interact with common foods high in potassium?

Because Low Centyl K contains potassium chloride, regulatory warnings note that its use may affect how the body handles potassium from food sources. Official information indicates that monitoring of blood potassium levels may be required to ensure they remain in the healthy range.

Q: How does Low Centyl K differ from generic potassium supplements?

Low Centyl K is officially described as a fixed-dose combination product containing two active ingredients: bendroflumethiazide (a diuretic) and potassium chloride (a potassium supplement). Generic potassium supplements contain only potassium chloride.

Q: Is Low Centyl K the same type of medicine as other drugs ending in '-K'?

The letter 'K' in Low Centyl K refers to the presence of potassium chloride as one of its two active ingredients. While other medications may also contain potassium, Low Centyl K is a combination product (a diuretic plus potassium), making it chemically distinct from single-ingredient potassium medicines.

Q: Is it common for people to feel a mild stomach discomfort when starting Low Centyl K?

Official patient information lists common side effects. Stomach upset or nausea are described in official documents as common side effects, meaning they may affect up to 1 in 10 people using the medicine.

Q: Can Low Centyl K affect my sleep schedule?

The medicine’s recommended morning dosing schedule is intended to prevent nocturia (waking up to urinate at night). Other possible side effects like dizziness or feeling weak are listed in regulatory documents and could indirectly affect daily energy or routines.

Q: Can Low Centyl K be used in children?

Official prescribing information focuses only on dosing and use for adults. Regulatory documents do not provide a specific regimen or guidance for its use in children, indicating it is not authorized for pediatric use.

Q: Is Low Centyl K considered a long-term treatment or short-term?

Low Centyl K is indicated for chronic conditions like high blood pressure and fluid retention. The description of a maintenance dose in regulatory documents aligns with treatment for chronic conditions that require long-term management.

Q: What official warnings or black box statements apply to Low Centyl K?

Regulatory documents include important warnings about potential severe effects. These warnings may concern severe hyperkalemia (dangerously high potassium), potential for gastrointestinal irritation or ulceration, and vision-related issues like acute angle-closure glaucoma.

Q: Are there any common interactions between Low Centyl K and pain relievers like ibuprofen?

Regulatory information advises caution when Low Centyl K is used alongside Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen. Official information notes the potential for increased risk of hyperkalemia (high potassium) and may also reduce the effectiveness of the diuretic component.

Q: Does Low Centyl K have any known interactions with herbal supplements?

Official drug labels list interactions with various classes of prescription medicines but generally do not provide an exhaustive list of every herbal supplement. Individuals are advised to inform their healthcare professional of all products they are using.

Q: Is it possible for Low Centyl K to interact with common allergy medications?

Official product documents describe interactions with various classes of medicines. This is because interactions are listed due to the potential for effects on electrolyte balance, such as hypokalaemia (low potassium levels) when combining certain drug types.

Q: What is the main reason Low Centyl K cannot be used with certain diuretics?

Regulatory information specifies that Low Centyl K is contraindicated for use with potassium-sparing diuretics. This is because the combination significantly increases the risk of severe hyperkalemia (dangerously high potassium levels) in the blood.

Q: Can older adults use Low Centyl K without special concerns?

Official information advises that dose selection should be cautious in older patients. This is due to the greater frequency of decreased kidney, liver, or heart function in this population, which can affect how the medicine is processed by the body.

Q: Can Low Centyl K be used by individuals who have diabetes?

The prescribing information includes a warning that the diuretic component may be associated with increased blood sugar levels or may affect the management of pre-existing diabetes. Official warnings state that adjustments to other medications may be necessary due to this effect.

Q: Can someone use Low Centyl K if they are pregnant or breastfeeding?

Regulatory guidance advises against using the medicine while pregnant or breastfeeding. This caution is noted because the drug's use is typically not recommended during pregnancy and it may potentially reduce milk supply during breastfeeding.

Q: Are there restrictions on driving or operating machinery while using Low Centyl K?

Official patient information advises individuals to avoid driving and operating machinery until they know how the medicine affects them. This caution is related to the potential for side effects such as dizziness or temporary visual changes that could impair ability.

Q: What happens if I miss a chance to take Low Centyl K?

Patient leaflets typically provide clear instructions for this situation. They generally advise that a person should not take a double dose to compensate for a missed one, but should continue with the next scheduled dose as planned.

Q: Is Low Centyl K available over the counter?

The medicine is described in official documents with specific dosing protocols, contraindications, and warnings that necessitate ongoing monitoring by a healthcare professional. These characteristics align with its classification as a prescription-only medicine.

Q: Are there different brand names for the same medicine as Low Centyl K?

Official documents define the medicine by its active chemical components, bendroflumethiazide and potassium chloride. This exact combination may be marketed and sold under various brand names globally, depending on the country and pharmaceutical manufacturer.

Q: What information is usually listed on the patient leaflet for Low Centyl K?

Patient leaflets (or Package Leaflets) generally include comprehensive information required by regulators. This covers details on what the medicine is, necessary precautions before taking it, instructions on how to take it, a list of possible side effects, and storage guidelines.

Q: What kind of studies support the use of Low Centyl K?

This evidence is aligned with the drug's indications (treatment of high blood pressure and fluid retention) and describes the pharmacological actions reviewed by regulatory authorities.

Q: Why is Low Centyl K sometimes mentioned in discussions about heart health?

Official product information indicates the medicine is authorized for the management of high blood pressure and fluid retention, which are conditions relevant to cardiovascular health. Official documentation also includes warnings related to potential effects on heart rhythm and function.

Q: Are there clinical trials focused on specific populations using Low Centyl K?

Official drug labels often include dedicated sections that discuss the medicine's use in specific populations, such as older adults or those with existing kidney issues. This information is based on clinical data gathered for or relevant to these specific groups.

Q: How is Low Centyl K cleared from the body?

Information in the official drug labels describes how the medicine is processed and indicates that the drug is substantially excreted by the kidney.

Q: Does Low Centyl K change how other medicines are absorbed?

The official drug label includes a section on drug interactions that outlines how the components may affect other medications. For example, some diuretics can affect the elimination rate of certain drugs, which can raise their concentration in the body.

Q: Is Low Centyl K a type of steroid?

The medicine is officially classified as a diuretic (a thiazide) and is not classified as a steroid.

Q: Does Low Centyl K impact blood sugar levels?

Yes, official documents include a warning that the diuretic component may be associated with increased blood sugar levels or may affect the management of pre-existing diabetes.

Q: Are the side effects of Low Centyl K typically mild or severe?

Official documents classify side effects by frequency. They list common effects that are usually experienced by many patients, but also list important, though less common, severe side effects that require immediate medical attention.

Q: What kind of monitoring might be required when taking Low Centyl K?

Regulatory warnings state that regular blood tests are often required, especially for checking potassium levels. This monitoring is advised for all patients, but is particularly crucial for those who are older or have heart or kidney issues.

Q: Is it possible to develop a dependency on Low Centyl K?

While dependency in the traditional sense is not typically listed in official documents, warnings note that stopping treatment suddenly may cause the original condition (such as high blood pressure) to worsen.

Q: What are the most common reasons someone might be ineligible to use Low Centyl K?

Reasons for ineligibility (contraindications) detailed in official documents may include severe kidney or liver problems, Addison's disease, gout, or having abnormal levels of key electrolytes like potassium, calcium, or sodium in the blood.

Q: What is the generally accepted dose range for Low Centyl K?

Regulatory documents specify the dose range based on the condition being treated. For example, official information details the dosage for high blood pressure and a flexible starting range for fluid retention, which is then adjusted to a maintenance dose.

How should Low Centyl K be stored and disposed of?

How to Store and Dispose of Low Centyl K

The storage and disposal of Low Centyl K (Bendroflumethiazide and Potassium Chloride) must adhere strictly to the conditions specified in official regulatory labeling to ensure product stability and safety.

Official Storage Requirements

  • Temperature: Do not store the tablets above 30 C.
  • Moisture Protection: The container must be kept tightly closed to protect the contents from moisture, which is essential for maintaining the product's 3-year shelf-life.
  • Child Safety: In line with general regulatory requirements for all medicines, the product must be kept out of the sight and reach of children.

Official Disposal Instructions

  • Waste Protocol: Any unused or expired medicinal product or waste material must be disposed of in accordance with local requirements, often through a pharmacy take-back scheme.
  • Environmental Restriction: The product should not be released into the environment; do not dispose of the tablets via household drains, sewers, or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Low Centyl K found in:

A-Z Index: